T-antigen Binding to the Merkel Cell Carcinoma Virus Origin
T-antigen Binding to the Merkel Cell Carcinoma Virus Origin
批准号:
7915366
负责人:
Alex ANDREW BOHM
金额:
$24.75万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-05-22 至 2011-04-30
关键词:
AffinityBase PairingBindingBinding SitesBiological ProcessC-terminalCapsidCellsComplexCopying ProcessesCrystallographyDNADNA FootprintDNA SequenceDNA Tumor VirusesDNA biosynthesisDrug DesignElementsFamilyFamily memberFutureGelHumanIn VitroIndividualLarge T AntigenLeadLightLinkMalignant NeoplasmsMerkel CellsMerkel cell carcinomaMethodsModelingNucleotidesOligonucleotidesPapillomavirusPolyomavirusPreparationProcessProteinsReplication OriginSequence HomologySimian virus 40Skin CancerStructureSystemTherapeuticVariantViralViral GenomeViral ProteinsViral Tumor AntigensVirusWorkantigen bindingbasecombatdesignds-DNAhelicaseinsightinterestmeltingmembermouse polyomaviruspolypeptidepublic health relevancesialosyl-T antigenstemstoichiometryviral DNA
中文摘要
描述(由申请人提供):默克尔细胞癌病毒(MCV)是最近发现的与侵袭性皮肤癌相关的多瘤病毒家族成员。我们对这种病毒的兴趣源于这样一个事实,即病毒复制起点的序列与更好地研究的家族成员(如鼠多瘤病毒和猿猴病毒40(SV 40))的序列显著不同。所有这些病毒在起源处都含有五聚体DNA序列GAGGC的多个拷贝,但MCV起源处含有比更好研究的病毒更多的拷贝和更紧密间隔的拷贝。在多瘤病毒中,单个蛋白质,即大T抗原,是起点识别、DNA解链和启动病毒基因组复制的宿主细胞蛋白质募集所需的全部。以前,我们已经确定了结合SV 40的GAGGC序列的T抗原结构域的晶体结构。基于这些结构,我们已经产生了T抗原结合MCV起源的初步模型。这些模型表明T抗原结构域之间的显着相互作用时,结合到DNA的MCV的起源,但这种相互作用中没有观察到的结构从SV 40系统。拟议的工作旨在确定是否发生预测的相互作用,并表征在MCV起源处形成的T-抗原-DNA复合物的结构。由于T抗原的N-和C-末端区域对于相关病毒的体外复制不是必需的,我们将集中于MCV起点结合结构域和解旋酶结构域。拟议的工作利用完善的方法,包括DNA足迹,凝胶位移和大分子晶体学。我们预计,这些研究将揭示病毒复制的重要的一般特征,并为未来旨在抑制MCV复制的努力提供一个结构平台。公共卫生相关性:默克尔细胞癌病毒(MCV)是感染人类的五种癌症相关DNA肿瘤病毒之一。拟议的项目旨在了解MCV蛋白,T抗原,如何与病毒DNA相互作用,以便开始复制病毒基因组的过程。我们预计,了解这一过程将导致治疗,打击MCV和相关病毒,通过阻止他们的能力,复制他们的DNA。
英文摘要
DESCRIPTION (provided by applicant): Merkel cell carcinoma virus (MCV) is a recently-discovered member of the polyomavirus family that is associated with an aggressive form of skin cancer. Our interest in this virus stems from the fact that the sequence of the viral origin of replication is significantly different from that of better studied family members such as murine polyomavirus and simian virus 40 (SV40). All of these viruses contain multiple copies of the pentameric DNA sequence GAGGC at the origin, but the MCV origin contains both more copies and more closely spaced copies than the better studied viruses. In polyomaviruses, a single protein, large T-antigen, is all that is required for origin recognition, DNA melting and the recruitment of host cell proteins that initiate replication of the viral genome. Previously we have determined crystal structures of the T-antigen domain that binds the GAGGC sequence from SV40. Based on these structures we have generated preliminary models of the T-antigen-bound MCV origin. These models suggest significant interaction between the T-antigen domains when bound to DNA at the MCV origin, but such interactions were not observed in structures from the SV40 system. The proposed work aims to determine if the predicted interactions take place and to characterize the structures of the T-antigen-DNA complexes formed at the MCV origin. Since the N- and C- terminal regions of T-antigen are not required for in vitro replication of related viruses, we will concentrate on the MCV origin- binding domain and the helicase domain. The proposed work utilizes well established methods including DNA footprinting, gel shifts, and macromolecular crystallography. We anticipate that these studies will both reveal important, general features of viral replication and provide a structural platform for future efforts aimed at inhibiting replication of MCV. PUBLIC HEALTH RELEVANCE: Merkel cell carcinoma virus (MCV) is one of five cancer-related DNA tumor viruses that infect humans. The proposed project aims to understand how the MCV protein, T-antigen, interacts with the viral DNA so as to begin the process of copying the viral genome. We anticipate that understanding this process will lead to therapeutics that combat MCV and related viruses by blocking their ability to replicate their DNA.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A structure-based approach to accelerated recombinase engineering
-
批准号:10078935
-
项目类别:
-
资助金额:$24.75万
-
财政年份:2018
-
负责人:Alex ANDREW BOHM
-
依托单位:
TBD+DNA
-
批准号:8363380
-
项目类别:
-
资助金额:$0.23万
-
财政年份:2011
-
负责人:Alex ANDREW BOHM
-
依托单位:
T-antigen Binding to the Merkel Cell Carcinoma Virus Origin
-
批准号:7642131
-
项目类别:
-
资助金额:$20.61万
-
财政年份:2009
-
负责人:Alex ANDREW BOHM
-
依托单位:
POLY(A) POLYMERASE AND FIP1 PEPTIDE COMPLEX
-
批准号:7726221
-
项目类别:
-
资助金额:$0.49万
-
财政年份:2008
-
负责人:Alex ANDREW BOHM
-
依托单位:
POLY(A) POLYMERASE AND FIP1 PEPTIDE COMPLEX
-
批准号:7602288
-
项目类别:
-
资助金额:$0.39万
-
财政年份:2007
-
负责人:Alex ANDREW BOHM
-
依托单位:
POLY(A) POLYMERASE OF S CEREVISEAE
-
批准号:7182508
-
项目类别:
-
资助金额:$0.19万
-
财政年份:2005
-
负责人:Alex ANDREW BOHM
-
依托单位:
TBD P65 FORM DNA SOAK/CO-CRYSTALLIZATION
-
批准号:7182507
-
项目类别:
-
资助金额:$0.85万
-
财政年份:2005
-
负责人:Alex ANDREW BOHM
-
依托单位:
Molecular Basis for Inhibition of Edema Factor
-
批准号:6730359
-
项目类别:
-
资助金额:$22.24万
-
财政年份:2004
-
负责人:Alex ANDREW BOHM
-
依托单位:
Molecular Basis for Inhibition of Edema Factor
-
批准号:6849728
-
项目类别:
-
资助金额:$20.85万
-
财政年份:2004
-
负责人:Alex ANDREW BOHM
-
依托单位:
Mechanism of poly(A) polymerase processivity
-
批准号:6771700
-
项目类别:
-
资助金额:$27.74万
-
财政年份:2002
-
负责人:Alex ANDREW BOHM
-
依托单位:
Mechanism of poly(A) polymerase processivity
-
批准号:6899899
-
项目类别:
-
资助金额:$26.35万
-
财政年份:2002
-
负责人:Alex ANDREW BOHM
-
依托单位:
Mechanism of poly(A) polymerase processivity
-
批准号:6824713
-
项目类别:
-
资助金额:$23.23万
-
财政年份:2002
-
负责人:Alex ANDREW BOHM
-
依托单位:
Mechanism of poly(A) polymerase processivity
-
批准号:6508531
-
项目类别:
-
资助金额:$38.62万
-
财政年份:2002
-
负责人:Alex ANDREW BOHM
-
依托单位:
Mechanism of poly(A) polymerase processivity
-
批准号:7088811
-
项目类别:
-
资助金额:$27.09万
-
财政年份:2002
-
负责人:Alex ANDREW BOHM
-
依托单位:
Mechanism of poly(A) polymerase processivity
-
批准号:6629469
-
项目类别:
-
资助金额:$6.72万
-
财政年份:2002
-
负责人:Alex ANDREW BOHM
-
依托单位:
海外基金